NCT03011645View on ClinicalTrials.gov

Gene-by-Stress Interactions in Intervention Studies Significance

PHASE1TerminatedINTERVENTIONAL

Enrollment

7

Participants

Timeline

Start Date

May 24, 2018

Primary Completion Date

January 28, 2020

Study Completion Date

January 28, 2020

Conditions

Cardiovascular Diseases

Interventions

DRUG

Ziprasidone

Given by mouth, single dose of 60 mg.

DRUG

Lorcaserin

Given by mouth, single dose of 20 mg.

DRUG

Placebo Oral Tablet

Given by mouth, single dose.

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Duke University

OTHER